BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19377492)

  • 1. Angina: Ivabradine for treatment of stable angina pectoris.
    de Silva R; Fox KM
    Nat Rev Cardiol; 2009 May; 6(5):329-30. PubMed ID: 19377492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.
    Tardif JC; Ponikowski P; Kahan T;
    Eur Heart J; 2009 Mar; 30(5):540-8. PubMed ID: 19136486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
    Tardif JC; Ford I; Tendera M; Bourassa MG; Fox K;
    Eur Heart J; 2005 Dec; 26(23):2529-36. PubMed ID: 16214830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative efficacy of ivabradine and atenolol in correction of clinical and functional parameters in patients with stable effort angina].
    Tatarchenko IP; Pozdniakova NV; Biriuchenko MV
    Kardiologiia; 2008; 48(5):60-1. PubMed ID: 18537806
    [No Abstract]   [Full Text] [Related]  

  • 5. [Stable angina pectoris. Effective symptom control and cardioprotection with ivabradine].
    MMW Fortschr Med; 2010 May; 152(21):102-3. PubMed ID: 20608138
    [No Abstract]   [Full Text] [Related]  

  • 6. Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.
    Sulfi S; Timmis AD
    Int J Clin Pract; 2006 Feb; 60(2):222-8. PubMed ID: 16451297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable angina: role of ivabradine unchanged between 2006 and 2010.
    Massé JF
    Prescrire Int; 2010 Nov; 19(110):264; author reply 264-5. PubMed ID: 21284363
    [No Abstract]   [Full Text] [Related]  

  • 8. Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice.
    Koester R; Kaehler J; Ebelt H; Soeffker G; Werdan K; Meinertz T
    Clin Res Cardiol; 2010 Oct; 99(10):665-72. PubMed ID: 20454968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart rate slowing versus other pharmacological antianginal strategies.
    Diaz A; Tardif JC
    Adv Cardiol; 2006; 43():65-78. PubMed ID: 16936473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ivabradine plus beta-blockers versus beta -blocker therapy only.
    Aalbers J
    Cardiovasc J Afr; 2010; 21(2):116. PubMed ID: 20532439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study.
    Tardif JC; Ponikowski P; Kahan T;
    Int J Cardiol; 2013 Sep; 168(2):789-94. PubMed ID: 23138014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W; Tendera M; Ford I; Fox KM
    Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Ivabradine in the Management of Angina Pectoris.
    Giavarini A; de Silva R
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):407-417. PubMed ID: 27475447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivabradine: new drug. Best avoided in stable angina.
    Prescrire Int; 2007 Apr; 16(88):53-6. PubMed ID: 17458043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focus on ivabradine: a new heart rate-controlling drug.
    Riccioni G
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):107-13. PubMed ID: 19210206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study.
    Werdan K; Ebelt H; Nuding S; Höpfner F; Hack G; Müller-Werdan U
    Clin Res Cardiol; 2012 May; 101(5):365-73. PubMed ID: 22231643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of the K(+) channel blocker tedisamil on hemodynamics, myocardial ischemia and neurohumoral systems in patients with stable angina pectoris. A comparison with the beta blocker atenolol].
    Mitrovic V; Miskovic A; Straub M; Beckmann K; Thormann J; Pitschner H
    Z Kardiol; 1999 Oct; 88(10):838-49. PubMed ID: 10552188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.
    Müller-Werdan U; Stöckl G; Ebelt H; Nuding S; Höpfner F; Werdan K;
    Exp Gerontol; 2014 Nov; 59():34-41. PubMed ID: 25193811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of ivabradine, a selective I(f) inhibitor, in patients with chronic stable angina pectoris and diabetes mellitus.
    Borer JS; Tardif JC
    Am J Cardiol; 2010 Jan; 105(1):29-35. PubMed ID: 20102886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new combination therapy in stable angina pectoris.
    Sajadieh A
    Eur Heart J; 2009 Mar; 30(5):524-5. PubMed ID: 19193673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.